Yu-Ping Luong

1.1k total citations
10 papers, 538 citations indexed

About

Yu-Ping Luong is a scholar working on Hepatology, Epidemiology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Yu-Ping Luong has authored 10 papers receiving a total of 538 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hepatology, 5 papers in Epidemiology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Yu-Ping Luong's work include Hepatitis C virus research (7 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Hepatitis B Virus Studies (4 papers). Yu-Ping Luong is often cited by papers focused on Hepatitis C virus research (7 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Hepatitis B Virus Studies (4 papers). Yu-Ping Luong collaborates with scholars based in United States. Yu-Ping Luong's co-authors include Robert B. Perni, Cynthia A. Gates, Yunyi Wei, Kai Lin, Chao Lin, B. Govinda Rao, Ann D. Kwong, John R. Fulghum, Debra Brennan and Sue Ma and has published in prestigious journals such as Journal of Biological Chemistry, Hepatology and Journal of Hepatology.

In The Last Decade

Yu-Ping Luong

10 papers receiving 510 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yu-Ping Luong United States	8	429	302	218	103	98	10	538
Roger Maurice Canada	11	475 1.1×	281 0.9×	223 1.0×	197 1.9×	187 1.9×	15	699
Tse‐I Lin Sweden	11	480 1.1×	377 1.2×	276 1.3×	126 1.2×	55 0.6×	30	670
Annick Scholliers United States	9	385 0.9×	320 1.1×	197 0.9×	49 0.5×	34 0.3×	11	500
S. Shane Taremi United States	11	359 0.8×	217 0.7×	159 0.7×	250 2.4×	111 1.1×	14	712
Peter T. Nower United States	14	767 1.8×	598 2.0×	360 1.7×	131 1.3×	85 0.9×	20	901
Marina Taliani Italy	7	246 0.6×	147 0.5×	162 0.7×	115 1.1×	117 1.2×	9	384
John P. Maxwell United States	8	212 0.5×	154 0.5×	107 0.5×	127 1.2×	47 0.5×	23	409
Kevin M. Cottrell United States	7	211 0.5×	153 0.5×	102 0.5×	173 1.7×	52 0.5×	21	413
Tatyana Dekhtyar United States	16	619 1.4×	495 1.6×	453 2.1×	103 1.0×	64 0.7×	32	868
Ted Halmos Canada	12	451 1.1×	215 0.7×	252 1.2×	255 2.5×	188 1.9×	15	747

Countries citing papers authored by Yu-Ping Luong

Since Specialization

Citations

This map shows the geographic impact of Yu-Ping Luong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu-Ping Luong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu-Ping Luong more than expected).

Fields of papers citing papers by Yu-Ping Luong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu-Ping Luong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu-Ping Luong. The network helps show where Yu-Ping Luong may publish in the future.

Co-authorship network of co-authors of Yu-Ping Luong

This figure shows the co-authorship network connecting the top 25 collaborators of Yu-Ping Luong. A scholar is included among the top collaborators of Yu-Ping Luong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu-Ping Luong. Yu-Ping Luong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Perni, Robert B., Gurudatt Chandorkar, Kevin M. Cottrell, et al.. (2007). Inhibitors of hepatitis C virus NS3·4A protease. Effect of P4 capping groups on inhibitory potency and pharmacokinetics. Bioorganic & Medicinal Chemistry Letters. 17(12). 3406–3411. 16 indexed citations

Lin, Chao, Cynthia A. Gates, B. Govinda Rao, et al.. (2005). In Vitro Studies of Cross-resistance Mutations against Two Hepatitis C Virus Serine Protease Inhibitors, VX-950 and BILN 2061. Journal of Biological Chemistry. 280(44). 36784–36791. 170 indexed citations

Perni, Robert B., J. PITLIK, John J. Court, et al.. (2004). Inhibitors of hepatitis C virus NS3·4A protease 2. Warhead SAR and optimization. Bioorganic & Medicinal Chemistry Letters. 14(6). 1441–1446. 41 indexed citations

Lin, Chao, Kai Lin, Yu-Ping Luong, et al.. (2004). In Vitro Resistance Studies of Hepatitis C Virus Serine Protease Inhibitors, VX-950 and BILN 2061. Journal of Biological Chemistry. 279(17). 17508–17514. 228 indexed citations

Lin, Chia‐Yuan, Kai Lin, Yu-Ping Luong, et al.. (2004). 59 VX-950, a novel HCV protease inhibitor, retains potency against BILN-2061 resitant replicon cells: Computational analysis indicates that resistance develops via different mechanisms. Journal of Hepatology. 40. 21–21. 1 indexed citations

Perni, Robert B., Lawrence F. Courtney, David D. Deininger, et al.. (2003). Inhibitors of hepatitis C virus NS3·4A protease 1. Non-Charged tetrapeptide variants. Bioorganic & Medicinal Chemistry Letters. 13(22). 4059–4063. 25 indexed citations

Perni, Robert B., Gurudatt Chandorkar, Lawrence F. Courtney, et al.. (2003). 972 VX-950: the discovery of an inhibitor of the hepatitis C NS3·4A protease and a potential hepatitis C virus therapeutic. Hepatology. 38. 624–624. 12 indexed citations

Lin, Kai, Cynthia A. Gates, Yu-Ping Luong, Robert B. Perni, & Ann D. Kwong. (2003). 137 VX-950: a tight-binding HCV protease inhibitor with a superior sustained inhibitory response in HCV replicon cells. Hepatology. 38. 222–222. 4 indexed citations

Golec, Julian M.C., Michael D. Mullican, Mark A. Murcko, et al.. (1997). Structure-based design of non-peptidic pyridone aldehydes as inhibitors of interleukin-1β converting enzyme. Bioorganic & Medicinal Chemistry Letters. 7(17). 2181–2186. 20 indexed citations

10.

Mullican, Michael D., Roger J. Gillespie, Saroop S. Matharu, et al.. (1994). The synthesis and evaluation of peptidyl aspartyl aldehydes as inhibitors of ice.. Bioorganic & Medicinal Chemistry Letters. 4(19). 2359–2364. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact